What they were paid
IONIS PHARMACEUTICALS Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $95,000 | $208,487 | $240,293 | $0 | $543,780 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IONIS PHARMACEUTICALS INC DEF 14A filed April 23, 2026, accession 0001140361-26-016388, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025IONIS PHARMACEUTICALS pays directors a $60,000 cash retainer and $448,780 in RSUs and Options.
Committees
FY2025 · as the proxy prints themAudit (Chair) · Finance
The rest of the IONIS PHARMACEUTICALS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Allene M. Diaz | Independent Director | $531,280 |
| Brett P. Monia | Director | $0 |
| Joan E. Herman | Independent Director | $541,280 |
| Joseph Loscalzo | Chair of the Board | $568,780 |
| Michael Hayden | Independent Director | $528,780 |
| Michael Yang | Independent Director | $518,780 |
| Spencer R. Berthelsen | Independent Director | $548,780 |
The full IONIS PHARMACEUTICALS compensation record
free company briefThis page is one director within IONIS PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat